International journal of nanomedicine · 2026
Levofloxacin-Catalase-PLGA Nanoparticles Potentiate Sonodynamic Therapy to Alleviate BCG-Induced Tuberculous Granulomas via PI3K/Akt/VEGF Pathway Suppression in Rats.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qiu Yan, Qin Liangrui, Shen Shangfeng, Zhang Yuqing, Du Yonghong, Li Dairong
Аннотация
PURPOSE: Hypoxic tuberculous granulomas induce vascular dysfunction and severely impede drug penetration. This study aimed to elucidate the molecular mechanism by which sonodynamic therapy (SDT) induces vascular normalization and synergistic immunomodulatory effects.
METHODS: Levofloxacin and catalase co-loaded PLGA nanoparticles (LEV@CAT-NPs) were prepared and characterized. Bacillus Calmette-Guérin (BCG) was used as a surrogate for virulent Mycobacterium tuberculosis due to its high biosafety. Therapeutic efficacy and mechanisms were evaluated in BCG-induced 3D tuberculous spheroids and a rat subcutaneous granuloma model via transcriptomic sequencing, Western blot, immunofluorescence, pharmacokinetic analysis, and bacterial load quantification.
RESULTS: LEV@CAT-NPs exhibited excellent stability and oxygen-generating capacity. SDT effectively alleviated intralesional hypoxia and downregulated HIF-1α and VEGF expression, promoting vascular normalization - evidenced by reduced vascular density, increased pericyte coverage, decreased leakage, improved perfusion, and enhanced tight junctions. Mechanistically, SDT inhibited the PI3K/Akt/VEGF pathway, reduced macrophage VEGF secretion, and induced macrophage apoptosis, thereby suppressing abnormal angiogenesis and improving drug penetration. The treatment also activated innate and adaptive immune pathways, promoting CD3⁺ and CD8⁺ T cell infiltration.
CONCLUSION: The SDT-driven mechano-chemical synergistic strategy effectively induces vascular normalization in tuberculous granulomas, improves drug delivery, and offers a promising approach for treating drug-resistant tuberculosis through microenvironment remodeling.
METHODS: Levofloxacin and catalase co-loaded PLGA nanoparticles (LEV@CAT-NPs) were prepared and characterized. Bacillus Calmette-Guérin (BCG) was used as a surrogate for virulent Mycobacterium tuberculosis due to its high biosafety. Therapeutic efficacy and mechanisms were evaluated in BCG-induced 3D tuberculous spheroids and a rat subcutaneous granuloma model via transcriptomic sequencing, Western blot, immunofluorescence, pharmacokinetic analysis, and bacterial load quantification.
RESULTS: LEV@CAT-NPs exhibited excellent stability and oxygen-generating capacity. SDT effectively alleviated intralesional hypoxia and downregulated HIF-1α and VEGF expression, promoting vascular normalization - evidenced by reduced vascular density, increased pericyte coverage, decreased leakage, improved perfusion, and enhanced tight junctions. Mechanistically, SDT inhibited the PI3K/Akt/VEGF pathway, reduced macrophage VEGF secretion, and induced macrophage apoptosis, thereby suppressing abnormal angiogenesis and improving drug penetration. The treatment also activated innate and adaptive immune pathways, promoting CD3⁺ and CD8⁺ T cell infiltration.
CONCLUSION: The SDT-driven mechano-chemical synergistic strategy effectively induces vascular normalization in tuberculous granulomas, improves drug delivery, and offers a promising approach for treating drug-resistant tuberculosis through microenvironment remodeling.